Neurologic complications of hematologic neoplasms

Neurologic Clinics

Volumn 21, Issue 1, 2003, Pages 87-105

  Recht, Lawrence ^a   Mrugala, Maciej ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN METASTASIS; CANCER CLASSIFICATION; CANCER INFILTRATION; CLINICAL FEATURE; HEMATOLOGIC MALIGNANCY; HEREDITY; HISTOPATHOLOGY; HUMAN; INFECTION; LEUKEMIA; LYMPHOMA; NEUROLOGIC DISEASE; PARANEOPLASTIC SYNDROME; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

CENTRAL NERVOUS SYSTEM DISEASES; HEMATOLOGIC NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 0037308334     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(02)00030-0     Document Type: Review

References (110)

1. Jaffe ES, Harris NL, Stein H, et al. Pathology & genetics. Tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001.
2. Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000;92:261-6.
3. Ferreri AJ, Reni M, Villa E. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol 2000;11:927-37.
4. Schlegel U, Schmidt-Wolf I, Deckert M. Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 2000; 181:1-12.
5. Thomas LB. Pathology of leukemia in the brain and meninges: postmortem studies of patients with acute leukemias and of mice given inoculations of L1210 leukemia. Cancer Res 1965;25:1555-71.
6. Mackintosh FR, Colby TV, Podolsky WJ, et al. Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer 1982;49:586-95.
7. Recht L, Straus DJ, Cirrincione C, et al. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis. Am J Med 1988;84:425-33.
8. Bunn PA, Schein PS, Banks PM, et al. Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited. Blood 1976; 47:3-10.
9. Wolf MM, Cooper IA, Olver IN, et al. Non-Hodgkin's lymphoma involving the central nervous system. Aust N Z J Med 1985;15:16-20.
10. Bleyer WA. Central nervous system leukemia. Pediatr Clin North Am 1988;35:789-814.
11. Peterson BA, Brunnig RD, Bloomfield CD, et al. Central nervous system involvement in acute nonlymphocytic leukemia; a prospective study of adults in remission. Am J Med 1987;83:464-70.
12. Glass JP, Van Tassel P, Keating MJ, et al. Central nervous system complications of a newly recognized subtype of leukemia: AMML with a pericentric inversion of chromosome 16. Neurology 1987;37:639-44.
13. Sheehan T, Cuthbert RJG, Parker AC. Central nervous system involvement in hematological malignancies. Clin Lab Haematol 1989;11:331-8.
14. Jellinger K, Radaszkiewicz T. Involvement of the central nervous system in malignant lymphomas. Virchows Arch [A] 1976;370:345-62.
15. Sariban E, Edwards B, Janus C, et al. Central nervous system involvement in American Burkitt's lymphoma. J Clin Oncol 1983;1:677-82.
16. Litam JP, Cabanillas F, Smith TL. Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis. Blood 1979;54:1249-57.
17. Law IP, Dick FR, Blom J, et al. Involvement of the central nervous system in non-Hodgkin's lymphoma. Cancer 1975;36:225-31.
18. Oda K, Egawa H, Okuhara T, et al. Meningeal involvement in Bence Jones multiple myeloma. Cancer 1991;67:1900-2.
19. Cairncross JG, Posner JB. Neurological complications of malignant lymphoma. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Amsterdam: North Holland Publishing; 1980. p. 27-62.
20. Lokich J, Galbo C. Leptomeningeal lymphoma: perspectives on management. Cancer Treat Rev 1981;8:103-10.
21. Griffin JW, Thompson RW, Mitchinson MJ, et al. Lymphomatous leptomeningitis. Am J Med 1971;51:200-8.
22. Young RC, Howser DM, Anderson T, et al. Central nervous system complications of non-Hodgkin's lymphoma: the potential role for prophylactic therapy. Am J Med 1979;66:435-43.
23. Glantz MJ, Cole BF, Glantz L, et al. Cerebrospinal fluid cytology in patients with cancer: how to minimize false negative results. Cancer 1998;82:733-9.
24. Cervantes F, Montserrat E, Rozman C. Eosinophilic meningitis in Hodgkin's disease. Ann Int Medicine 1979;91:930.
25. Dillman RO, Mueh J, Greco CM, et al. Leptomeningeal Hodgkin's disease. Ann Int Med 1980;92:714-5.
26. Glantz MJ, Cole BF, Recht LD, et al. High dose intravenous methotrexate for patients with leptomeningeal carcinomatosis: Is intrathecal chemotherapy necessary? J Clin Oncol 1998;16:1561-7.
27. Glantz MJ, Jaeckle KA, Chamberlain MC, et al. Phase III trial comparing intrathecal sustained release cytarabine (DepoCytTM) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 1999;5:3394-402.
28. Glantz MJ, Hall WA, Cole BF, et al. Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer 1995; 75:2919-31.
29. Raz I, Siegal T, Siegal T, et al. CNS involvement by non-Hodgkin's lymphoma: response to a standard therapeutic protocol. Arch Neurol 1984;41:1167-71.
30. Venables GS, Proctor SJ, Bates D, et al. Intracranial disease in non-Hodgkin's lymphoma. Quart J Med 1980;49:111-31.
31. Levitt LJ, Dawson DM, Rosenthal DS, et al. CNS involvement in the non-Hodgkin's lymphomas. Cancer 1980;45:545-52.
32. Herman TS, Hammond N, Jones SE, et al. Involvement of the central nervous system by non-Hodgkin's lymphoma: the Southwest Oncology Group experience. Cancer 1979;43:390-7.
33. Hallahan D, Griem M, Griem S, et al. Mycosis fungoides involving the central nervous system. J Clin Oncol 1986;4:1638-44.
34. Sapoznik MD, Kaplan HS. Intracranial Hodgkin's disease: a report of 12 cases and review of the literature. Cancer 1983;52:1301-7.
35. Friedman M, Kim TH, Panahon AM. Spinal cord compression in malignant lymphoma: treatment and results. Cancer 1976;37:1485-91.
36. Colak A, Cataltepe O, Erbengi A. Spinal cord compression caused by plamacytomas: a retrospective series of 14 cases. Neurosurg Rev 1989;12:305-8.
37. Speiss JL, Adelstein DJ, Hines JD. Multiple myeloma presenting with spinal cord compression. Oncology 1988;45:88-92.
38. Wiernik PH, Serpick AA. Granulocytic sarcoma (chloroma). Blood 1970;35:361-9.
39. Kim FSC, Rutka JT, Bernstein M, et al. Intradural granulocytic sarcoma presenting as a lumbar radiculopathy. J Neurosurg 1990;72:663-7.
40. Barnett MJ, Zussman WV. Granulocytic sarcoma of the brain: a case report and review of the literature. Radiology 1986;160:223-5.
41. DiMarco A, Campostrini F, Garusi GF. Non-Hodgkin lymphomas presenting with spinal epidural involvement. Acta Oncol 1989;28:485-8.
42. Eeles RA, O'Brien PO, Horwich A, et al. Non-Hodegkin's lymphoma presenting with extradural spinal cord compression: functional outcome and survival. Br J Cancer 1991;63:126-9.
43. Goffinet DR, Warnke R, Dunnick NR, et al. Clincal and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. Cancer Treat Rep 1977;61:981-92.
44. Hollis PH, Malis LI, Zappulla RA. Neurological deterioration after lumbar puncture below complete spinal subarachnoid block. J Neurosurg 1986;64:253-6.
45. Maranzano E, Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiation Biol Phys 1995;32:959-67.
46. Gilbert RW, Kim J, Posner JB. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 1978;3:40-51.
47. Ratanatharathorn V, Powers WE. Epidural spinal cord compression from metastatic tumor: diagnosis and guidelines for management. Cancer Treat Rev 1991;18:55-71.
48. Byrne TN. Spinal cored compression from epidural metastases. N Engl J Med 1992; 327:614-9.
49. McDonald AC, Nicoll JA, Rampling RP. Non-Hodgkin's lymphoma presenting with spinal cord compression: a clinicopathological review of 25 cases. Eur J Cancer 2000; 36:207-13.
50. Bellan LD, Cox TA, Gascoyne RD. Parasellar syndrome caused by plasma cell dyscrasia. Can J Ophthalmol 1989;24:331-4.
51. Knapp AJ, Gartner S, Henkind P. Multiple myeloma and its ocular manifestations. Surg Ophthalmol 1987;31:343-51.
52. Shone GR. Facial palsy due to myeloma of the temporal bone. J Laryngol Otol 1985;99:907-8.
53. Lossos A, Siegal T. Numb chin syndrome in cancer patients: etiology, response to treatment and prognostic significance. Neurology 1992;42:1181-4.
54. Massey EW, Moore J, Schold SC. Mental neuropathy from systemic cancer. Neurology 1981;31:1277-81.
55. Kuroda Y, Fujiyama F, Ohyama T, et al. Numb chin syndrome secondary to Burkitt's cell acute leukemia. Neurology 1991;41:453-4.
56. Quinones-Hinojosa A, Friedlander RM, Boyer PJ, et al. Solitary sciatic nerve lymphoma as an initial manifestation of diffuse neurolymphatosis: case report and review of the literature. J Neurosurg 2000;92:165-9.
57. Guberman A, Rosenbaum H, Braiciale T, et al. Human neurolymphomatosis. J Neurol Sci 1978;36:1-2.
58. Schoenfeld Y, Aderka D, Sandbank U, et al. Fatal peripheral neurolymphomatosis after remission of histiocytic lymphoma. Neurology 1983;33:243-5.
59. Evans AE. Central nervous system involvement in children with leukemia. Cancer 1964;17:256-8.
60. Sullivan MP, Chen T, Dyment PG, et al. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a Pediatric Oncology Group study. Blood 1982;60:948-58.
61. Skarin AT, Rosenthal DS, Moloney WC, et al. Combination chemotherapy of advanced non-Hodgkin's lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP). Blood 1977;49:759-70.
62. Ersboll J, Schultz HB, Thomsen B, et al. Meningeal involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment. Scand J Hematol 1985; 35:487-96.
63. Johnson GJ, Oken MM, Anderson JR, et al. Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: Is prophylaxis indicated? Lancet 1984;2:685-7.
64. Haioun C, Besson C, Lepage E, et al. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Ann Oncol 2000;11:685-90.
65. Monfardini S, Ficarra G, Giardini R, et al. Central nervous system involvement in non-Hodgkin's lymphomas: value of lumbar puncture as initial staging procedure. Tumori 1981;67:197-202.
66. Perez-Soler R, Smith TL, Cabanillas F. Central nervous system prophylaxis with combined intravenous and intrathecal methotrexate in diffuse lymphomas of aggressive histologic type. Cancer 1986;57:971-7.
67. Salata RA, Kling RE, Gose F, et al. Listeria monocytogenes cerebritis, bacteremia, and cutaneous lesions complicating hairy cell leukemia. Am J Med 1986;81:1068-72.
68. Foreman NK, Molt MG, Parkyr TM, et al. Mycotic intracranial abscesses during induction treatment for acute lymphoblastic leukemia. Arch Dis Child 1988;63:436-8.
69. Dykes A, Baraff LJ, Herzog P. Listeria brain abscess in an immunosuppressed child. J Pediatr 1979;94:72-4.
70. Kimmel DW, Hermann RC, O'Neill BP. Neurologic complications of hairy cell leukemia. Arch Neurol 1984;41:202-3.
71. Chernik NL, Armstrong D, Posner JB. Central nervous system infections in patients with cancer. Medicine (Baltimore) 1973;52:563-81.
72. Goffinet DR, Glatstein EJ, Merigan TC. Herpes zoster-varicella infections and lymphoma. Ann Int Medicine 1972;76:235-40.
73. Mazur MH, Dolin R. Herpes zoster at the NIH: a twenty year experience. Am J Med 1978;65:738-44.
74. Straus SE, Croen KD. Varicella-zoster virus infections: biology, natural history, treatment, and prevention. Ann Int Medicine 1988;108:221-37.
75. Fritz RD, Forkner CE, Freireich EJ, et al. The association of fatal intracranial hemorrhage and "blastic crisis" in patients with acute leukemia. N Engl J Med 1959;261:59-64.
76. Nagpal RD. Dural sinus and cerebral venous thrombosis. Neurosurg Rev 1983;6:155-60.
77. Lockman LA, Mastir A, Priest JR, et al. Dural venous sinus thrombosis in acute lymphoblastic leukemia. Pediatrics 1980;66:943-7.
78. David RB, Hadfield MG, Vines FS, et al. Dural sinus occlusion in leukemia. Pediatrics 1974;56:793-6.
79. Sigsbee B, Deck M, Posner JB. Nonmetastatic superior sagittal sinus thrombosis complicating systemic cancer. Neurology 1979;29:139-46.
80. Feinberg WM, Swenson MR. Cerebrovascular complications of L-asparaginase therapy. Neurology 1988;38:127-33.
81. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 1985;64:16-35.
82. Tojo K, Morita A, Miki T, et al. IgA myeloma complicated by fractures of the bones and hyperviscosity syndrome: report of an autopsied case. Osaka City Med J 1990;36:61-70.
83. MacKenzie MR, Babcock J. Studies in the hyperviscosity syndromell: Macroglobulinemia. J Lab Clin Med 1975;35:227-34.
84. Somer T. Hyperviscosity syndrome in plasma cell dyscrasias. Adv Microcirc 1975;6:1-70.
85. MacKenzie MR, Lee TK. Blood viscosity in Waldenstrom macroglobulinemia. Blood 1977;49:507-10.
86. Bernard A, Rousselie F. Macular manifestations of monoclonal dysgammaglobulinemias: apropos of 3 cases. J Fr Ophthalmol 1986;9:805-10.
87. Damon LE, Mass R, Linker CA. The association between high-dose cytarabine neurotoxicity and renal insufficiency. J Clin Oncol 1989;48:1563-8.
88. Lazarus HM, Herzig RH, Herzig GP, et al. Central nervous system toxicity of high-dose systemic cytosine arabinoside. Cancer 1981;48:2577-82.
89. Jaffe N, Takaue Y, Anzai T, et al. Transient cerebral dysfunction secondary to high-dose methotrexate. Cancer 1985;56:1356-60.
90. Walker RW, Allen JC, Rosen G, et al. Transient cerebral dysfunction secondary to high-dose methotrexate. J Clin Oncol 1986;4:1845-50.
91. Yap HY, Blumenschein GR, Yap BS, et al. High-dose methotrexate for advanced breast cancer. Cancer Treat Rep 1979;63:757-61.
92. Gagliano RG, Costanzi JJ. Paraplegia following intrathecal methotrexate: report of a case and review of the literature. Cancer 1976;37:1663-8.
93. Hahn AF, Feasby TE, Gilbert JJ. Paraparesis following intrathecal chemotherapy. Neurology 1983;33:1032-8.
94. Bleyer WA. Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep 1981;65(Suppl 1):89-98.
95. Glass JP, Lee YY, Burner J, et al. Treatment-related leukoencephalopathy: a study of three cases and literature review. Medicine (Baltimore) 1986;65:154-62.
96. McIntosh S, Fischer DB, Rothman S, et al. Chronic neurologic disturbance in childhood leukemia. Cancer 1976;37:853-7.
97. Peylan-Ramu N, Poplack D, Pizzo P, et al. Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med 1978;298:815-8.
98. Tucker J, Prior PF, Green CR, et al. Minimal neuropsycological sequelae following prophylactic treatment of the central nervous system in adult leukemia and lymphoma. Br J Cancer 1989;60:775-80.
99. Brazis PW, Biller J, Fine M, et al. Cerebellar degeneration with Hodgkin's disease: computed tomographic correlation and literature review. Arch Neurol 1981;38:253-6.
100. Julien J, Vital C, Aupy G, et al. Guillain-Barre syndrome in Hodgkin's disease: ultrastructural study of a peripheral nerve. J Neurol Sci 1980;45:23-7.
101. Lisak RP, Mitchell M, Zweiman B, et al. Guillain-Barre syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol 1977;1:72-8.
102. Pezzimenti JF, Bruckner HW, DeConti RC. Paralytic brachial neuritis in Hodgkin's disease. Cancer 1973;31:626-9.
103. Rowland LP, Schneck SA. Neuromuscular disorders associated with malignant neoplastic disease. J Chronic Dis 1963;16:777-95.
104. Schold SC, Cho ES, Somasundaram M, et al. Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol 1981;38:271-87.
105. Walton JN, Tomlinson BE, Pearce GW. Subacute "poliomyelitis" and Hodgkin's disease. J Neurol Sci 1968;6:435-45.
106. Younger DS, Rowland LP, Latov N, et al. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol 1991;29:78-86.
107. Kelly JJ. Polyneuropathies associated with plasma cell dyscrasias. Semin Neurol 1987;7:30-9.
108. Kelly JJ, Kyle RA, O'Brien PC, et al. The natural history of peripheral neuropathy in primary systemic amyloidosis. Ann Neurol 1979;6:1-7.
109. Bisail M, Cossu A, Massarelli G, et al. POEMS syndrome: a case report. Haematologica 1990;75:384-6.
110. Hyman BT, Westrick MA. Multiple myeloma and coagulopathy: a case report of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes. POEMS syndrome. Arch Int Med 1986;146:993-4.